EP1991569A4 - Natively glycosylated mammalian biological molecules produced by eletromagnetically stimulating living mammalian cells - Google Patents

Natively glycosylated mammalian biological molecules produced by eletromagnetically stimulating living mammalian cells

Info

Publication number
EP1991569A4
EP1991569A4 EP06748309A EP06748309A EP1991569A4 EP 1991569 A4 EP1991569 A4 EP 1991569A4 EP 06748309 A EP06748309 A EP 06748309A EP 06748309 A EP06748309 A EP 06748309A EP 1991569 A4 EP1991569 A4 EP 1991569A4
Authority
EP
European Patent Office
Prior art keywords
eletromagnetically
biological molecules
molecules produced
mammalian cells
natively glycosylated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06748309A
Other languages
German (de)
French (fr)
Other versions
EP1991569A2 (en
Inventor
Thomas J Goodwin
Donnie Rudd
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Regenetech Inc
National Aeronautics and Space Administration NASA
Original Assignee
Regenetech Inc
National Aeronautics and Space Administration NASA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regenetech Inc, National Aeronautics and Space Administration NASA filed Critical Regenetech Inc
Publication of EP1991569A2 publication Critical patent/EP1991569A2/en
Publication of EP1991569A4 publication Critical patent/EP1991569A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2053—IL-8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
EP06748309A 2006-03-07 2006-03-07 Natively glycosylated mammalian biological molecules produced by eletromagnetically stimulating living mammalian cells Withdrawn EP1991569A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2006/008071 WO2007102812A2 (en) 2006-03-07 2006-03-07 Natively glycosylated mammalian biological molecules produced by eletromagnetically stimulating living mammalian cells

Publications (2)

Publication Number Publication Date
EP1991569A2 EP1991569A2 (en) 2008-11-19
EP1991569A4 true EP1991569A4 (en) 2009-12-23

Family

ID=38475285

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06748309A Withdrawn EP1991569A4 (en) 2006-03-07 2006-03-07 Natively glycosylated mammalian biological molecules produced by eletromagnetically stimulating living mammalian cells

Country Status (4)

Country Link
EP (1) EP1991569A4 (en)
CN (1) CN101213206A (en)
IL (1) IL188396A0 (en)
WO (1) WO2007102812A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2944019B1 (en) * 2009-04-03 2011-04-22 Biomerieux Sa METHOD FOR DETERMINING PRODEFENSIN-A6 FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER
US9428813B2 (en) 2012-03-26 2016-08-30 The United States Of America, As Represented By The Secretary, Dept. Of Health & Human Services DNA methylation analysis for the diagnosis, prognosis and treatment of adrenal neoplasms
CA3007299A1 (en) * 2015-12-03 2017-06-08 The Brigham And Women's Hospital, Inc. Methods for generating functional hematopoietic stem cells
CN107541790B (en) * 2016-06-24 2021-07-06 上海交通大学 Human agglutinin/human-like agglutinin chip for glycosylation detection and preparation method thereof
CN113252616B (en) * 2021-01-29 2022-05-03 厦门大学 Glycosylation research method of exosome

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986003520A1 (en) * 1984-12-04 1986-06-19 Genetics Institute, Inc. Method for the production of erythropoietin
GB2169312A (en) * 1985-01-02 1986-07-09 Beaconsfield Tina A method for producing proteins
US20050009161A1 (en) * 2002-11-01 2005-01-13 Jackson Streeter Enhancement of in vitro culture or vaccine production using electromagnetic energy treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6348191B1 (en) * 1986-07-08 2002-02-19 Genetics Institute, Inc. Production and use of IL-6
US20070048253A1 (en) * 2004-06-30 2007-03-01 Goodwin Thomas J Natively glycosylated mammalian biological molecules produced by electromagnetically stimulating living mammalian cells

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986003520A1 (en) * 1984-12-04 1986-06-19 Genetics Institute, Inc. Method for the production of erythropoietin
GB2169312A (en) * 1985-01-02 1986-07-09 Beaconsfield Tina A method for producing proteins
US20050009161A1 (en) * 2002-11-01 2005-01-13 Jackson Streeter Enhancement of in vitro culture or vaccine production using electromagnetic energy treatment

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
FISHER S J ET AL: "EFFECT OF A PULSED ELECTROMAGNETIC FIELD ON PLASMA MEMBRANE PROTEIN GLYCOSYLATION", JOURNAL OF BIOELECTRICITY, vol. 5, no. 2, 1986, pages 253 - 268, XP009125275, ISSN: 0730-823X *
HOGLUND M: "GLYCOSYLATED AND NON-GLYCOSYLATED RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR (RHG-CSF) - WHAT IS THE DIFFERENCE?", MEDICAL ONCOLOGY, SCIENCE AND TECHNOLOGY LETTERS, NORTHWOOD, GB, vol. 15, no. 4, 1 December 1998 (1998-12-01), pages 229 - 233, XP009027777, ISSN: 1357-0560 *
KUBOTA N ET AL: "Structural characterization of natural and recombinant human granulocyte colony-stimulating factors.", JOURNAL OF BIOCHEMISTRY MAR 1990, vol. 107, no. 3, March 1990 (1990-03-01), pages 486 - 492, XP009125309, ISSN: 0021-924X *
LELKES P I ET AL: "GTSF-2: a new, versatile cell culture medium for diverse normal and transformed mammalian cells.", IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY. ANIMAL MAY 1997, vol. 33, no. 5, May 1997 (1997-05-01), pages 344 - 351, XP002553931, ISSN: 1071-2690 *

Also Published As

Publication number Publication date
WO2007102812A2 (en) 2007-09-13
EP1991569A2 (en) 2008-11-19
WO2007102812A3 (en) 2007-12-21
IL188396A0 (en) 2008-08-07
CN101213206A (en) 2008-07-02
WO2007102812A9 (en) 2008-02-21

Similar Documents

Publication Publication Date Title
IL285655B (en) System for conducting the identification of bacteria in biological samples
EP1891201A4 (en) Pharmacokinetic-based culture system with biological barriers
IL218754A0 (en) System for conducting the indentification of bacteria in biological samples
EP2029781A4 (en) Biochemical analysis of partitioned cells
EP2064314A4 (en) Cell culture improvements
PL1977225T3 (en) Electrochemical biosensor analysis system
EP2300880A4 (en) Analysis of transparent biological objects
SG10201503304RA (en) Cell culture processes
EP2028264A4 (en) Cell incubator
GB0617983D0 (en) Biological fluid analysis system
ZA200900392B (en) Biological production of fuels
EP2011857A4 (en) Method of producing cell culture container
EP2346387B8 (en) Blood analysis
IL184262A (en) Cell culture method
EP2128242A4 (en) Cell culture module
GB0517382D0 (en) Cell culture
IL188396A0 (en) Natively glycosylated mammalian biological molecules prouced by eletromagnetically stimulating living mammalian cells
EP2185720A4 (en) Biological encoding of large numbers of cells
EP2336355A4 (en) Biological rhythm prediction method
EP2196194A4 (en) Process for producing biological ingesta and biological ingesta obtained thereby
BRPI0719262A2 (en) METABOLIC GENETIC TRANSFORMATION OF ARABINOSIS FERMENTING Yeast CELLS
GB0813339D0 (en) Novel reagents and method for conjugating biological molecules
AU2007901277A0 (en) Analysis of Ribonucleic Acid
GB0905762D0 (en) Novel reagents and method for conjugating biological molecules
GB0605321D0 (en) Nucleic acid molecules

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080124

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

A4 Supplementary search report drawn up and despatched

Effective date: 20091120

17Q First examination report despatched

Effective date: 20100310

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100921